Loading company…
Walking Fish Therapeutics develops B cell therapies for cancer, rare diseases, and autoimmune conditions.
Founded in 2019 and based in South San Francisco, Walking Fish Therapeutics develops B cell therapies, including recombinant antibody treatments. In February 2022, it raised USD 12.7 mn in Series A funding co-led by First Spark Ventures and Northpond Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in